For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...
In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a new initiative to significantly reduce, refine, and replace animal testing ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results